|Bid||2.2800 x 0|
|Ask||2.1700 x 0|
|Day's Range||2.2250 - 2.3100|
|52 Week Range||1.5750 - 5.9300|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 30, 2019 - Sep 3, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.32|
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, is pleased to announce that it has acquired the intellectual property rights over microencapsulated technology developed by Bionova. This transaction will allow Elixinol to utilize the microencapsulated technology globally.
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, recently announced that its parent company Elixinol Global (EXL) has raised A$50 million through the issue of approximately 12.8 million shares at A$3.90 per share to institutional investors. Proceeds acquired will be used to further expand operations in Colorado, Elixinol’s U.S. headquarters. The rapid growth displayed here is set to amplify the company’s presence in the U.S. by increasing production facilities in Colorado by an additional ~23,000 square feet to more than double the company’s current production capacity.
DENVER, June 03, 2019 -- Elixinol issued the following statement regarding the public FDA hearing in Washington, D.C. on Friday, May 31. “We support the FDA’s intentions, we.
How far off is Elixinol Global Limited (ASX:EXL) from its intrinsic value? Using the most recent financial data, we'll...
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has been officially granted a CBD Processor Research Partner Authorization by the New York State Department of Agriculture and Markets. The Department promotes New York agriculture and its high-quality and diverse products, fosters agricultural environmental stewardship, and safeguards the State’s food supply, land, and livestock to ensure the viability and growth of New York’s agriculture industries.
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have partnered with Cambrian Alliance (CA), one of the largest buying groups for independent pharmacies in the United Kingdom. The partnership allows CA members to access Elixinol brand products, an exclusive launch offer package, point of sale material and staff training. “We are delighted to work in partnership with Elixinol, providing our members with access to a new range of products,” said Nathan Wiltshire, CEO of Cambrian Alliance.
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that they have purchased a 25 percent stake in Altmeds LLC, maker of the pioneering and market leading Pet Releaf hemp-derived CBD pet line. Pet Releaf hemp-derived CBD topical, edibles and oils for pets currently sell in over 4,000 independent pet stores throughout the USA and multiple international markets. “Pet Releaf and Elixinol share the same values in sourcing and end-product superiority,” said Stephen Smith, President and Co-Founder of Pet Releaf.
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces its latest product in partnership with Ken Brown, MD of KBMD Health, KBMD CBD Extract in Elixinol’s signature Natural and Cinnamint flavors. Created in partnership with Dr. Brown, an established physician specializing in gastroenterology, this full-spectrum product contains 900mg of CBD in a 1oz tincture, and is intended to help promote abdominal health and support relief from discomfort in those impacted by digestive issues. Passionate about bridging the gap between natural and medical science, Dr. Brown has been utilizing Elixinol hemp CBD extract for over two years in his own gastroenterology practice to support the digestive wellness of hundreds of patients.
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, today announced that it has received U.S. Hemp Authority™ Certification. The prestigious certification has only been granted to a total of 14 companies to date, and grants Elixinol the ability to use the Certified Seal of the U.S. Hemp Authority on all hemp product packaging and marketing materials. The U.S. Hemp Authority Certification Program is the hemp industry’s initiative to provide high standards, best practices, and self-regulation, in an effort to give confidence to consumers and law enforcement that hemp products are safe and legal.
DENVER, April 12, 2019 -- Elixinol Global Limited (EXL or the Company) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp, dietary supplements and.
Charlotte's Web Holdings Inc. and Elixinol Global Ltd. are pioneers in hemp/CBD. Elixinol, the fastest over the second half of 2018, has new, cutting-edge products and a lower relative valuation. Charlotte's Web's Q4 sales rebounded after a hiccup in Q3 and had solid Q/Q sales growth of 21%.
DENVER, March 18, 2019 -- Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces a new take on a.
Elixinol, one of the most influential CBD brands in the world with nearly three decades of experience in the hemp industry, announces its latest product innovation, Create | Build | Dream (C | B | D), a full-spectrum water-soluble hemp CBD powder. “Our CBD powders are all-natural, taste great and mix well with beverages, no matter the time of day,” said Chris Husong, Elixinol’s Sales & Marketing Director.
SYDNEY, Australia, Feb. 27, 2019 -- Elixinol Global Limited (EXL or the Group) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp and emerging medicinal.
OTCQX: ELLXF), has expanded its EU operations with key personnel hires and offices in the Netherlands, Spain, and the United Kingdom. The appointments are accompanied by a new go-to-market strategy and key initiatives including the launch of new e-commerce capabilities, sales hubs, with 12 full-time sales and marketing employees, in the Netherlands, Spain, and the United Kingdom aimed at capturing the European cannabis market opportunity, which analysts expect will be worth more than $130 billion in annual sales by 2028 (in today’s dollars).
SAN FRANCISCO, Feb. 05, 2019 -- Fincom Investment Partners discusses Elixinol Global Ltd.'s (EXL:ASX; ELLXF:OTCQX) Q4 earnings, and the hemp/CBD field. Company mentioned:.
Leading global hemp CBD company Elixinol, has announced its entry into the New Zealand marketplace, offering its comprehensive range of cannabidiol (CBD) products to the NZ public on a prescription basis via the elixinol.com website. OTCQX: ELLXF) and has launched in New Zealand following the December 2018 passage of New Zealand’s Misuse of Drugs (Medicinal Cannabis) Amendment Act.
The announcement comes on the heels of the December 2018 passage of New Zealand’s Misuse of Drugs (Medicinal Cannabis) Amendment Act which classifies CBD, with low levels of THC as prescription medicine and removes CBD as a Class B1 controlled drug. Individual patients may now import up to a 3-month supply of CBD products, provided those products meet prescription medicine guidelines. Medicinal practitioners, pharmacies may also import and sell CBD products as can individuals or companies holding a license to sell medicines in New Zealand.
OTC: ELLXF), announces Joy Beckerman’s appointment to Elixinol’s team starting January 1, 2019. In Beckerman’s role as Regulatory Officer and Industry Liaison, she will advise Elixinol’s executive team on the industry’s changes and ensure Elixinol’s practices continue to meet or exceed the requirements of hemp’s dynamic regulatory framework following the 2018 Farm Bill which federally legalized hemp.
OTCQX: ELLXF), a global company operating in the hemp, dietary supplements and emerging medicinal cannabis sectors, is delighted to announce that the President of the United States has signed the 2018 Farm Bill, which includes the Hemp Farming Act of 2018 (S.2667), confirming the Bill has now been fully passed and enacted into law. As a result, hemp has been officially removed from the Controlled Substances Act (hemp removed from the definition of marijuana) and will now be regulated as an agricultural crop.
SAN FRANCISCO, Dec. 18, 2018 -- The U.S. Congress passed the 2018 Farm Bill that legalizes hemp; the bill is expected to be signed by the President soon. Against this backdrop,.
DENVER, Dec. 11, 2018 -- US-based Elixinol announces the distribution of its first globally available, all-natural, hemp-based skin care and hair care line, Sativa. The 8.
OTCQX: ELLXF), achieved a milestone in the U.S. by reporting retail sales approaching seven figures over the Thanksgiving shopping holiday. The record revenue was buoyed by increased U.S. consumer demand and Elixinol’s annual U.S. “Buy One Get One” promotion over the U.S. Thanksgiving holiday shopping weekend. 5% of all elixinol.com sales are donated to charity benefiting veterans and various health organizations. “I co-founded this business with a global vision to give everyone, from individuals to organizations, the opportunity to enjoy hemp’s restorative benefits,” said Paul Benhaim, Elixinol Global CEO and Elixinol co-founder.
To ease that frustration, Elixinol, the world’s most trusted CBD brand, is offering Buy-One-Get-One (BOGO) on Elixinol products on elixinol.com exclusively for Black Friday and Cyber Monday. In addition to BOGO, Elixinol recently announced Free Shipping for all U.S. orders. “We only do this once per year, but it’s a great opportunity because this is easily the best value in premium CBD,” said Chris Husong, Director of Sales & Marketing for Elixinol.